Editorial : Something old, something few, something subjective, something Dé jà Vu

Journal of Clinical Oncology

Volumn 21, Issue 1, 2003, Pages 1-2

  Horning, Sandra J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHOP B PROTOCOL; CHOP-B PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

COMPARATIVE STUDY; HUMAN; LYMPHOCYTOMA; MIXED CELL LYMPHOMA; NOTE; PATHOLOGY;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, MIXED-CELL, FOLLICULAR; LYMPHOMA, SMALL CLEAVED-CELL, FOLLICULAR; PREDNISONE; VINCRISTINE;

EID: 0037208611     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.18.114     Document Type: Editorial

References (11)

1. Peterson BA, Petroni GA, Frizzera G: Prolonged single agent versus combination chemotherapy in indolent follicular lymphomas. A study of the Cancer and Leukemia Group B. J Clin Oncol 21:5-15, 2003.
2. Longo DL, Young RC, Hubbard SM, et al: Prolonged initial remission in patients with nodular mixed lymphoma. Ann Intern Med 100:651-656, 1984.
3. Glick JH, Barnes JM, Ezdinli EZ, et al: Nodular mixed lymphoma: Results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 58:920-925, 1981.
4. Dana BW, Dahlberg S, Nathwani BN, et al: Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicinbased chemotherapy or chemoimmunotherapy. J Clin Oncol 11:644-651, 1993.
5. Metter GE, Nathwani BN, Burke JS, et al: Morphological subclassification of follicular lymphoma: Variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies. J Clin Oncol 3:25-38, 1985.
6. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17:3835-3849, 1999.
7. Nathwani BN, Harris NL, Weisenburger D, et al: Follicular lymphoma, in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. Lyon, IARC Press, 2001, pp 162-167.
8. Bartlett NL, Rizeq M, Dorfman RF, et al: Follicular large-cell lymphoma: Intermediate or low grade? J Clin Oncol 12:1349-1357, 1994.
9. Martin AR, Weisenburger DD, Chan WC, et al: Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85:3671-3678, 1995.
10. Solal-Celigny P, Bernard J, Roy P: Follicular lymphoma international prognostic project (FLIPP). Ann Oncol 13:18, Abstract 54, 2002.
11. Horsman DE, Connors JM, Pantzar T, et al: Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 30:375-382, 2001.